Latest News about Pharma/Biotech
Recent news which mentions Pharma/Biotech
From TalkMarkets
Alvotech's Share Price At A Critical Juncture
April 13, 2024
From TalkMarkets
Viking Therapeutics: Strong Results In Obesity
April 13, 2024
From TalkMarkets
From TalkMarkets
Week In Review: ProfoundBio, A Seattle-Suzhou ADC Biotech, Acquired By Genmab For $1.8 Billion
April 06, 2024
From TalkMarkets
Tuesday Talk: April Is The Cruelest Month?
April 02, 2024
From TalkMarkets
Healthcare And Biotech Stocks Review: Q1 2024 Performance
April 01, 2024
From TalkMarkets
2 Top Biotech Buyout Candidates
March 31, 2024
From TalkMarkets
March Recap: Largest Psychedelic Drug Stocks Up Another 5%
March 30, 2024
From TalkMarkets
Week In Review: AriBio Sells China Rights To Alzheimer’s Candidate In $770 Million Deal
March 30, 2024
From TalkMarkets
Tuesday Talk: Big-Tech Under Attack
March 26, 2024
From TalkMarkets
From TalkMarkets
From TalkMarkets
Healthcare And Biotech Update With Market At 2024 Highs
March 20, 2024
From TalkMarkets
Tickers
ASX
From TalkMarkets
From TalkMarkets
From TalkMarkets
From TalkMarkets
It's A Bull Market But Harder To Pick Small Cap Biotech Winners Because Of Volatility
March 11, 2024
From TalkMarkets
What A Trip: Psychedelic Medicine Company MindMed Shares Rocket 50% After Positive Data
March 10, 2024
Tickers
MNMD
From TalkMarkets
5 Biotechnology Stocks To Buy For A Stable Portfolio In 2024
March 09, 2024
From TalkMarkets
From TalkMarkets
Pharma Stock Roundup: Novo Nordisk's New Obesity Pill Data, Roche, AstraZeneca's Pipeline Updates
March 09, 2024
From TalkMarkets
NuGen Medical’s Needle-Free Injection Could Be Game-Changer
March 07, 2024
Tickers
NGMDF
From TalkMarkets
Landos Biopharma - Investor Like It Better Than Analysts
March 07, 2024
Tickers
LABP
From TalkMarkets
From TalkMarkets
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.